Trial Profile

A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive- Controlled, Crossover Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alalevonadifloxacin (Primary)
Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
Focus Adverse reactions
Sponsors Wockhardt

Most Recent Events

12 Apr 2016 Results of part-I of study, determining the electrocardiographic effects of WCK 2349 (n=48) presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
28 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
24 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com